Skip Navigation

VAERS Bibliography - February 2004

  1. HHS-CDC NEWS: Racial/Ethnic Disparities in Influenza and Pneumococcal Vaccination Levels Among Persons Aged >65 Years--United States, 1989-2001. Ann.Pharmacother. 38 (1): 195; January, 2004.

  2. Measles Outbreak Associated With an Imported Case in an Infant--Alabama, 2002. MMWR Morb.Mortal.Wkly.Rep. 53 (2): 30-33; January 23, 2004.

  3. Measles Mortality Reduction--West Africa, 1996-2002. MMWR Morb.Mortal.Wkly.Rep. 53 (2): 28-30; January 23, 2004.

  4. Recommended Childhood and Adolescent Immunization Schedule--United States, January-June 2004.   MMWR Morb.Mortal.Wkly.Rep. 53 (1): Q1-Q4; January 16, 2004.

  5. Allen, U. Reply to Measles Vaccination in Canada. J.Pediatr. 144 (1): 141; January, 2004.

  6. Augey, F.; Legoff, D.; Chouvet, B. [Bullous Eruption After Influenza Virus Vaccination]. Ann.Dermatol.Venereol. 130 (11): 1058-1060; November, 2003.

  7. Breen, D. Pneumococcal Vaccination Programme in Over 65s and at-Risk Groups: the Dumfries and Galloway Experience. Commun.Dis.Public Health. 6 (3): 228-230; September, 2003.

  8. Cardenosa, N.; Dominguez, A.; Martinez, A.; Alvarez, J.; Panella, H.; Godoy, P.; Minguell, S.; Camps, N.; Vazquez, J. A. Meningococcal Disease in Catalonia 1 Year After Mass Vaccination Campaign With Meningococcal Group C Polysaccharide Vaccine. Infection. 31 (6): 392-397; December, 2003.

  9. Chowdhury, A. M.; Bhuiya, A.; Mahmud, S.; Abdus Salam, A. K.; Karim, F. Immunization Divide: Who Do Get Vaccinated in Bangladesh?   J.Health Popul.Nutr. 21 (3): 193-204; September, 2003.

  10. Cooper, B. W. Smallpox Vaccination Risks and Public Policy. Ann.Intern.Med. 140 (1): 67; January 6, 2004.

  11. Cox, R. J.; Brokstad, K. A.; Ogra, P. Influenza Virus: Immunity and Vaccination Strategies. Comparison of the Immune Response to Inactivated and Live, Attenuated Influenza Vaccines. Scand.J.Immunol. 59 (1): 1-15; January, 2004.

  12. D'Heilly, S. J.; Lockman, J. L.; Nichol, K. L. Adherence of Mass Vaccinators to Timing Guidelines for Influenza Vaccination. Am.J.Prev.Med. 26 (1): 46-50; January, 2004.

  13. Daley, M. F.; Barrow, J.; Pearson, K.; Crane, L. A.; Gao, D.; Stevenson, J. M.; Berman, S.; Kempe, A. Identification and Recall of Children With Chronic Medical Conditions for Influenza Vaccination. Pediatrics. 113 (1 Pt 1): e26-e33; January, 2004.

  14. Davies, P.; Nwokoro, C.; Leigh, M. Vaccinations Against Influenza and Pneumococcus in Children With Diabetes: Telephone Questionnaire Survey. BMJ. 328 (7433): 203; January 24, 2004.

  15. Deshpande, S. A. Ethnic Differences in the Rates of BCG Vaccination. Arch.Dis.Child. 89 (1): 48-49; January, 2004.

  16. Fedson, D. S. Vaccination for Pandemic Influenza: a Six Point Agenda for Interpandemic Years. Pediatr.Infect.Dis.J. 23 (1): S74-S77; January, 2004.

  17. Filipovic, T.; Grzetic, R.; Sviderek-Stalekar, D. Earlier Detection of Amblyopia and Strabismus by Ophthalmologic Screening Card Attached to the Vaccination Card. Can.J.Ophthalmol. 38 (7): 587-592; December, 2003.

  18. Frick, K. D.; Colchero, M. A.; Dean, D. Modeling the Economic Net Benefit of a Potential Vaccination Program Against Ocular Infection With Chlamydia Trachomatis. Vaccine. 22 (5-6): 690-697; January 26, 2004.

  19. Ginsberg, G. M.; Somekh, E. Cost Containment Analysis of Childhood Vaccination Against Varicella in Israel. J.Infect. 48 (2): 119-133; February, 2004.

  20. Halliday, L.; Thomson, J. A.; Roberts, L.; Bowen, S.; Mead, C. Influenza Vaccination of Staff in Aged Care Facilities in the ACT: How Can We Improve the Uptake of Influenza Vaccine? Aust.N.Z.J.Public Health. 27 (1): 70-75; 2003.

  21. Hammerschmidt, T.; Banz, K.; Wagenpfeil, S.; Neiss, A.; Wutzler, P. Economic Evaluation of Varicella Vaccination Programmes: a Review of the Literature. Pharmacoeconomics. 22 (2): 133-138; 2004.

  22. Henke, A.; Jarasch, N.; Wutzler, P.  Vaccination Procedures Against Coxsackievirus-Induced Heart Disease. Expert.Rev.Vaccines. 2 (6): 805-815; December, 2003.

  23. Jokhdar, H.; Borrow, R.; Sultan, A.; Adi, M.; Riley, C.; Fuller, E.; Baxter, D. Immunologic Hyporesponsiveness to Serogroup C but Not Serogroup A Following Repeated Meningococcal A/C Polysaccharide Vaccination in Saudi Arabia. Clin.Diagn.Lab Immunol. 11 (1): 83-88; January, 2004.

  24. Katz, S. L. Measles Vaccination in Canada. J.Pediatr. 144 (1): 141; January, 2004.

  25. Kermode, M.; Yong, K.; Hurley, S.; Marmion, B. An Economic Evaluation of Increased Uptake in Q Fever Vaccination Among Meat and Agricultural Industry Workers Following Implementation of the National Q Fever Management Program. Aust.N.Z.J.Public Health. 27 (4): 390-398; 2003.

  26. Kissam, S.; Gifford, D. R.; Patry, G.; Bratzler, W. Is Signed Consent for Influenza or Pneumococcal Polysaccharide Vaccination Required?   Arch.Intern.Med. 164 (1): 13-16; January 12, 2004.

  27. Kuno, G. Serodiagnosis of Flaviviral Infections and Vaccinations in Humans. Adv.Virus Res. 61:3-65; 2003.

  28. Lajeunesse, M. An Overview of Vaccination Against Infectious Disease in Children in 2003. Expert.Rev.Vaccines. 2 (5): 611-614; October, 2003.

  29. Lawrence, G. L.; MacIntyre, C. R.; Hull, B. P.; McIntyre, P. B. Measles Vaccination Coverage Among Five-Year-Old Children: Implications for Disease Elimination in Australia. Aust.N.Z.J.Public Health. 27 (4): 413-418; 2003.

  30. Lindholm, C.; Naylor, A.; Johansson, E. L.; Quiding-Jarbrink, M. Mucosal Vaccination Increases Endothelial Expression of Mucosal Addressin Cell Adhesion Molecule 1 in the Human Gastrointestinal Tract. Infect.Immun. 72 (2): 1004-1009; February, 2004.

  31. McVernon, J.; Morgan, P.; Mallaghan, C.; Biswas, T.; Natarajan, M.; Griffiths, D.; Slack, M.; Moxon, R. Outbreak of Haemophilus Influenzae Type b Disease Among Fully Vaccinated Children in a Day-Care Center. Pediatr.Infect.Dis.J. 23 (1): 38-41; January, 2004.

  32. McVernon, J.; Mitchison, N. A.; Moxon, E. R. T Helper Cells and Efficacy of Haemophilus Influenzae Type b Conjugate Vaccination. Lancet Infect.Dis. 4 (1): 40-43; January, 2004.

  33. Meltzer, M. I. Risks and Benefits of Preexposure and Postexposure Smallpox Vaccination. Emerg.Infect.Dis. 9 (11): 1363-1370; November, 2003.

  34. Meyers, D. G. Could Influenza Vaccination Prevent Myocardial Infarction, Stroke and Sudden Cardiac Death? Am.J.Cardiovasc.Drugs. 3 (4): 241-244; 2003.

  35. Milani, V.; Endres, M.; Kuppner, M. C.; Issels, R. D.; Noessner, E. [Heat Shock Proteins, Immune Competence and Vaccination]. Dtsch.Med.Wochenschr. 129 (1-2): 31-35; January 2, 2004.

  36. Nokleby, H. [Vaccination of Persons With Allergy]. Tidsskr.Nor Laegeforen. 123 (23): 3400-3401; January 9, 2004.

  37. Parker, N. R. Positive Q Fever Skin Test After Vaccination. Med.J.Aust. 180 (1): 45-46; January 5, 2004.

  38. Poccia, F.; Gioia, C.; Montesano, C.; Martini, F.; Horejsh, D.; Castilletti, C.; Pucillo, L.; Capobianchi, M. R.; Ippolito, G. Flow Cytometry and T-Cell Response Monitoring After Smallpox Vaccination. Emerg.Infect.Dis. 9 (11): 1468-1470; November, 2003.

  39. Polk, B. [Who Should Get an Influenza Vaccination?]. Med.Monatsschr.Pharm. 26 (12): 429; December, 2003.

  40. Postma, M. J.; Heijnen, M. L.; Beutels, P.; Jager, J. C. Pharmacoeconomics of Elderly Vaccination Against Invasive Pneumococcal Infections: Cost-Effectiveness Analyses and Implications for The Netherlands. Expert.Rev.Vaccines. 2 (4): 477-482; August, 2003.

  41. Premenko-Lanier, M.; Rota, P.; Rhodes, G.; Bellini, W.; McChesney, M. Prior DNA Vaccination Does Not Interfere With the Live-Attenuated Measles Vaccine. Vaccine. 22 (5-6): 763-766; January 26, 2004.

  42. Puig-Barbera, J. [Vaccinations and Pregnancy (I): Vaccines That Are Indicated for Pregnant Women]. Aten.Primaria. 33 (1): 38-43; January, 2004.

  43. Sankar, P.; Schairer, C.; Coffin, S. Public Mistrust: The Unrecognized Risk of the CDC Smallpox Vaccination Program. Am.J.Bioeth. 3 (4): 22-25; 2003.

  44. Shapiro, Y.; Shemer, J.; Heymann, A.; Shalev, V.; Maharshak, N.; Chodik, G.; Green, M. S.; Kokia, E. Influenza Vaccination: Reduction in Hospitalizations and Death Rates Among Members of "Maccabi Healthcare Services" During the 2000-2001 Influenza Season. Isr.Med.Assoc.J. 5 (10): 706-708; October, 2003.

  45. Sipetic, S.; Vlajinac, H.; Kocev, N.; Radmanovic, S.  The Belgrade Childhood Diabetes Study: Association of Infections and Vaccinations on Diabetes in Childhood. Ann.Epidemiol. 13 (9): 645-651; October, 2003.

  46. Sleigh, K. M.; Marra, F. H.; Stiver, H. G. Influenza Vaccination: Is It Appropriate in Chronic Fatigue Syndrome?   Am.J.Respir.Med. 1 (1): 3-9; 2002.

  47. Staszewski, V.; Boulinier, T. Vaccination: a Way to Address Questions in Behavioral and Population Ecology?   Trends Parasitol. 20 (1): 17-22; January, 2004.

  48. Sun, W.; Edelman, R.; Kanesa-Thasan, N.; Eckels, K. H.; Putnak, J. R.; King, A. D.; Houng, H. S.; Tang, D.; Scherer, J. M.; Hoke, C. H., Jr.; Innis, B. L. Vaccination of Human Volunteers With Monovalent and Tetravalent Live-Attenuated Dengue Vaccine Candidates. Am.J.Trop.Med.Hyg. 69 (6 Suppl): 24-31; December, 2003.

  49. Thiry, N.; Beutels, P.; Van Damme, P.; Van Doorslaer, E. Economic Evaluation of Varicella Vaccination Programmes: a Review of the Literature. The Authors' Reply. Pharmacoeconomics. 22 (2): 136-138; 2004.

  50. Tomar, R. P. Pulse Polio Immunization: a Need for More Inputs. Indian J.Pediatr. 70 (11): 930; November, 2003.

  51. Whitham, M.; Blannin, A. K. The Effect of Exercise Training on the Kinetics of the Antibody Response to Influenza Vaccination. J.Sports Sci. 21 (12): 991-1000; December, 2003.

  52. Zimmerman, R. K. Recommended Childhood and Adolescent Immunization Schedule, United States, January to June, 2004 and Update on Childhood Immunizations. Am.Fam.Physician. 69 (1): 206-211; January 1, 2004.

  53. Zweiman, B.; Rothenberg, M. E. Sisk Et Al. Cost-Effectiveness of Vaccination Against Invasive Pneumococcal Disease Among People 50 Through 64 Years of Age: Role of Comorbid Conditions and Race. Ann Intern Med 2003 17;138:960-8. J.Allergy Clin.Immunol. 113 (1): 186; January, 2004.

[Top]